首页> 外文期刊>Theranostics >Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy
【24h】

Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy

机译:用于光声/磁共振的钆螯合缀合的聚合物基纳米移植术/ NIR-II荧光显影引导癌光热疗法

获取原文
           

摘要

Our exploiting versatile multimodal theranostic agent aims to integrate the complementary superiorities of photoacoustic imaging (PAI), second near-infrared (NIR-II, 1000-1700) fluorescence and Tsub1/sub-weighted magnetic resonance imaging (MRI) with an ultimate objective of perfecting cancer diagnosis, thus improving cancer therapy efficacy. Herein, we engineered and prepared a water-soluble gadolinium-chelated conjugated polymer-based theranostic nanomedicine (PFTQ-PEG-Gd NPs) for in vivo tri-mode PA/MR/NIR-II imaging-guided tumor photothermal therapy (PTT). Methods : We firstly constructed a semiconducting polymer composed of low-bandgap donor-acceptor (D-A) which afforded the strong NIR absorption for PAI/PTT and long fluorescence emission to NIR-II region for in vivo imaging. Then, the remaining carboxyl groups of the polymeric NPs could effectively chelate with Gdsup3+/sup ions for MRI. The in vitro characteristics of the PFTQ-PEG-Gd NPs were studied and the in vivo multimode imaging as well as anti-tumor efficacy of the NPs was evaluated using 4T1 tumor-bearing mice. Results : The obtained theranostic agent showed excellent chemical and optical stability as well as low biotoxicity. After 24 h of systemic administration using PQTF-PEG-Gd NPs, the tumor sites of living mice exhibited obvious enhancement in PA, NIR-II fluorescence and positive MR signal intensities. Better still, a conspicuous tumor growth restraint was detected under NIR light irradiation after administration of PQTF-PEG-Gd NPs, indicating the efficient photothermal potency of the nano-agent. Conclusion : we triumphantly designed and synthesized a novel and omnipotent semiconducting polymer nanoparticles-based theranostic platform for PAI, NIR-II fluorescence imaging as well as positive MRI-guided tumor PTT in living mice. We expect that such a novel organic nano-platform manifests a great promise for high spatial resolution and deep penetration cancer theranostics.
机译:我们利用多媒体Horanostic代理人旨在整合光声成像(PAI)的互补优势,第二次近红外(NIR-II,1000-1700)荧光和T 1 - 重量磁共振成像(MRI )具有完善癌症诊断的最终目标,从而提高癌症治疗疗效。在此,我们设计并制备了用于体内三型PA / MR / NIR-II成像引导的肿瘤光热疗法(PTT)的水溶性钆 - 螯合缀合的聚合物基治疗纳米胺(PFTQ-PEG-GD NPS)。方法:首先构建了由低带隙供体 - 受体(D-A)组成的半导体聚合物,该聚合物构成了用于PAI / PTT的强NIR吸收和在体内成像中的NIR-II区域的强荧光发射。然后,聚合物NP的剩余羧基可以有效地与Gd 3 + / sup>离子螯合用于MRI。研究了PFTQ-PEG-GD NP的体外特征,并使用4T1携带的小鼠评估NPS的体内多模成像以及NPS的抗肿瘤效果。结果:所获得的治疗剂显示出优异的化学和光学稳定性以及低生物毒性。使用PQTF-PEG-GD NPS的全身施用24小时后,生物小鼠的肿瘤位点在PA,NIR-II荧光和阳性MR信号强度中表现出明显的增强。在给予PQTF-PEG-GD NPS之后的NIR光照射下,更好地检测到显着的肿瘤生长约束,表明纳米剂的有效光热效力。结论:我们胜利地设计和合成了一种新的和无所不连的半导体聚合物纳米颗粒,用于PAI,NIR-II荧光成像的基于HITHOSTIC平台以及生物小鼠的阳性MRI引导肿瘤PTT。我们预计这种新颖的有机纳米平台表现出对高空间分辨率和深层渗透癌治疗的最佳许可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号